# Role of Intraoperative Thymoglobulin in Decreasing Ischemia-Reperfusion Injury in Pediatric Heart Transplant Recipients

> **NCT00709293** · NA · WITHDRAWN · sponsor: **University of California, Los Angeles**

## Conditions studied

- Ischemia Reperfusion Injury
- Heart Transplantation

## Interventions

- **DRUG:** Anti-Thymocyte Globulin
- **DRUG:** Normal Saline

## Key facts

- **NCT ID:** NCT00709293
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-07
- **Primary completion:** 2009-05
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Insufficient funding
- **Last updated:** 2013-06-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00709293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00709293, "Role of Intraoperative Thymoglobulin in Decreasing Ischemia-Reperfusion Injury in Pediatric Heart Transplant Recipients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00709293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*